de Verneuil Vanina 4
4 · Vir Biotechnology, Inc. · Filed Nov 7, 2025
Insider Transaction Report
Form 4
de Verneuil Vanina
EVP, General Counsel, Corp Sec
Transactions
- Sale
Common Stock
2025-11-05$5.16/sh−2,385$12,307→ 78,210 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2024.